NovaSom, an Obstructive Sleep Apnea (OSA) management company, announced recently that it has closed $35 million in equity financing. The investment was led by Safeguard Scientifics, as well as ...
Frequent snoring can be a red flag for mild obstructive sleep apnea (OSA), a commonly undiagnosed condition. The eXciteOSA device is an FDA-authorized daytime therapy designed to strengthen tongue ...
Wellness shoppers eyeing Pulsetto want to know one thing before they commit: how fast does the four-minute-a-day device actually work on sleep? Here is what the company, its CEO and its data say about ...
With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of OSA severity, opening new revenue opportunities for Vivos LITTLETON, Colo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results